ORAMED PHARMACEUTICALS INC. Issues Form 144 for July 1
Published on Β· Source: investing.com
AI Summary
Summarized by AI from the source belowOramed Pharmaceuticals Inc. (ORMP) filed Form 144 on July 1. A Form 144 is typically filed by insiders to notify the SEC of their intention to sell shares. This filing may indicate potential selling pressure, which could impact market sentiment regarding ORMP. Understanding Form 144 filings is crucial for investors tracking insider trading activity and assessing potential effects on stock prices.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
